These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 16843267)
1. STAT1 acts as a tumor promoter for leukemia development. Kovacic B; Stoiber D; Moriggl R; Weisz E; Ott RG; Kreibich R; Levy DE; Beug H; Freissmuth M; Sexl V Cancer Cell; 2006 Jul; 10(1):77-87. PubMed ID: 16843267 [TBL] [Abstract][Full Text] [Related]
2. Cell-autonomous and -nonautonomous contributions of STAT1 in murine models of tumorigenesis. Rocnik JL; Gilliland DG Cancer Cell; 2006 Jul; 10(1):1-2. PubMed ID: 16843258 [TBL] [Abstract][Full Text] [Related]
3. JunB is a gatekeeper for B-lymphoid leukemia. Ott RG; Simma O; Kollmann K; Weisz E; Zebedin EM; Schorpp-Kistner M; Heller G; Zöchbauer S; Wagner EF; Freissmuth M; Sexl V Oncogene; 2007 Jul; 26(33):4863-71. PubMed ID: 17297445 [TBL] [Abstract][Full Text] [Related]
4. The role of STAT1/IRF-1 on synergistic ROS production and loss of mitochondrial transmembrane potential during hepatic cell death induced by LPS/d-GalN. Lee HJ; Oh YK; Rhee M; Lim JY; Hwang JY; Park YS; Kwon Y; Choi KH; Jo I; Park SI; Gao B; Kim WH J Mol Biol; 2007 Jun; 369(4):967-84. PubMed ID: 17475277 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D. Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507 [TBL] [Abstract][Full Text] [Related]
6. Essential role for signal transducer and activator of transcription-1 in pancreatic beta-cell death and autoimmune type 1 diabetes of nonobese diabetic mice. Kim S; Kim HS; Chung KW; Oh SH; Yun JW; Im SH; Lee MK; Kim KW; Lee MS Diabetes; 2007 Oct; 56(10):2561-8. PubMed ID: 17620422 [TBL] [Abstract][Full Text] [Related]
7. Searching for leukemia stem cells--not yet the end of the road? Jordan CT Cancer Cell; 2006 Oct; 10(4):253-4. PubMed ID: 17045202 [TBL] [Abstract][Full Text] [Related]
8. MHC class I antigens and immune surveillance in transformed cells. Aptsiauri N; Cabrera T; Garcia-Lora A; Lopez-Nevot MA; Ruiz-Cabello F; Garrido F Int Rev Cytol; 2007; 256():139-89. PubMed ID: 17241907 [TBL] [Abstract][Full Text] [Related]
9. Protein kinase C-theta is required for NK cell activation and in vivo control of tumor progression. Aguiló JI; Garaude J; Pardo J; Villalba M; Anel A J Immunol; 2009 Feb; 182(4):1972-81. PubMed ID: 19201850 [TBL] [Abstract][Full Text] [Related]
10. Doxorubicin directs the accumulation of interleukin-12 induced IFN gamma into tumors for enhancing STAT1 dependent antitumor effect. Zhu S; Waguespack M; Barker SA; Li S Clin Cancer Res; 2007 Jul; 13(14):4252-60. PubMed ID: 17634555 [TBL] [Abstract][Full Text] [Related]
11. Interleukin-15 improves cytotoxicity of natural killer cells via up-regulating NKG2D and cytotoxic effector molecule expression as well as STAT1 and ERK1/2 phosphorylation. Zhang C; Zhang J; Niu J; Zhang J; Tian Z Cytokine; 2008 Apr; 42(1):128-36. PubMed ID: 18280748 [TBL] [Abstract][Full Text] [Related]
12. Antitumor effects of Mucin 1/sec involves the modulation of urokinase-type plasminogen activator and signal transducer and activator of transcription 1 expression in tumor cells. Ilkovitch D; Handel-Fernandez ME; Herbert LM; Lopez DM Cancer Res; 2008 Apr; 68(7):2427-35. PubMed ID: 18381451 [TBL] [Abstract][Full Text] [Related]
14. T and B lymphocytes exert distinct effects on the homeostasis of NK cells. Jeannet G; Coudert JD; Held W Eur J Immunol; 2006 Oct; 36(10):2725-34. PubMed ID: 16955521 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-15 expression affects homeostasis and function of B cells through NK cell-derived interferon-gamma. Gill N; Paltser G; Ashkar AA Cell Immunol; 2009; 258(1):59-64. PubMed ID: 19361783 [TBL] [Abstract][Full Text] [Related]
16. A small-molecule enhancer of signal transducer and activator of transcription 1 transcriptional activity accentuates the antiproliferative effects of IFN-gamma in human cancer cells. Lynch RA; Etchin J; Battle TE; Frank DA Cancer Res; 2007 Feb; 67(3):1254-61. PubMed ID: 17283162 [TBL] [Abstract][Full Text] [Related]
17. Gfi1 negatively regulates T(h)17 differentiation by inhibiting RORgammat activity. Ichiyama K; Hashimoto M; Sekiya T; Nakagawa R; Wakabayashi Y; Sugiyama Y; Komai K; Saba I; Möröy T; Yoshimura A Int Immunol; 2009 Jul; 21(7):881-9. PubMed ID: 19505891 [TBL] [Abstract][Full Text] [Related]
18. Heat shock protein-90 inhibitors increase MHC class I-related chain A and B ligand expression on multiple myeloma cells and their ability to trigger NK cell degranulation. Fionda C; Soriani A; Malgarini G; Iannitto ML; Santoni A; Cippitelli M J Immunol; 2009 Oct; 183(7):4385-94. PubMed ID: 19748980 [TBL] [Abstract][Full Text] [Related]
19. Germ-line and rearranged Tcrd transcription distinguish bona fide NK cells and NK-like gammadelta T cells. Stewart CA; Walzer T; Robbins SH; Malissen B; Vivier E; Prinz I Eur J Immunol; 2007 Jun; 37(6):1442-52. PubMed ID: 17492716 [TBL] [Abstract][Full Text] [Related]
20. Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide. Shackelford D; Kenific C; Blusztajn A; Waxman S; Ren R Cancer Res; 2006 Dec; 66(23):11360-9. PubMed ID: 17145882 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]